Matthew K. Tobin

Dr. Matthew K. Tobin

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2020 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
MTMatthew K. Tobin
Matthew K. Tobin
TSTerilyn K. L. Stephen
Terilyn K. L. Stephen
KLKyra L. Lopez
Kyra L. Lopez
MPMelissa R. Pergande
Melissa R. Pergande
ABAmelia M. Bartholomew
Amelia M. Bartholomew
OLOrly Lazarov
Orly Lazarov
Background: Brain repair mechanisms fail to promote recovery after stroke, and approaches to induce brain regeneration are scarce. Mesenchymal stem cells ( MSC ) are thought to be a promising therapeutic option. However, their efficacy is not fully elucidated, and the mechanism underlying their effect is not known. Methods and Results: The middle cerebral artery occlusion model was utilized to determine the efficacy of interferon‐γ–activated mesenchymal stem cells ( aMSC γ) as an acute therapy for stroke. Here we show that treatment with aMSC γ is a more potent therapy for stroke than naive MSC . aMSC γ treatment results in significant functional recovery assessed by the modified neurological severity score and open‐field analysis compared with vehicle‐treated animals. aMSC γ‐treated animals showed significant reductions in infarct size and inhibition of microglial activation. The aMSC γ treatment suppressed the hypoxia‐induced microglial proinflammatory phenotype more effectively than treatment with naive MSC . Importantly, treatment with aMSC γ induced recruitment and differentiation of oligodendrocyte progenitor cells to myelin‐producing oligodendrocytes in vivo. To elucidate the mechanism underlying high efficacy of aMSC γ therapy, we examined the secretome of aMSC γ and compared it to that of naive MSC . Intriguingly, we found that aMSC γ but not nMSC upregulated neuron‐glia antigen 2, an important extracellular signal and a hallmark protein of oligodendrocyte progenitor cells. Conclusions: These results suggest that activation of MSC with interferon‐γ induces a potent proregenerative, promyelinating, and anti‐inflammatory phenotype of these cells, which increases the potency of aMSC γ as an effective therapy for ischemic stroke.

1 February 2021 in World Neurosurgery
Verified
Journal Article
Closed access
MTMatthew K. Tobin
Matthew K. Tobin
CGCristian Gragnaniello
Cristian Gragnaniello
JHJack Horwitz
Jack Horwitz
FSFelicia W. Sun
Felicia W. Sun
CSConstantin Schizas
Constantin Schizas
SNSergey Neckrysh
Sergey Neckrysh

14 November 2025 in Annals of Clinical and Translational Neurology
Verified
Journal Article
Open access
RKRahul R. Karamchandani
Rahul R. Karamchandani
DWDylan N. Wolman
Dylan N. Wolman
TBTyler M. Bielinski
Tyler M. Bielinski
NGNitin Goyal
Nitin Goyal
JRJeremy B. Rhoten
Jeremy B. Rhoten
PHPhilipp Hendrix
Philipp Hendrix
Objective: To compare the effectiveness and safety of tenecteplase (TNK) versus alteplase (TPA) in patients with basilar artery occlusion prior to endovascular treatment (EVT). Methods: In this retrospective multicenter study (BAO‐TNK), we analyzed consecutive BAO patients from 14 U.S. stroke systems who received TNK or TPA within 4.5 h of last known well and were referred for EVT (01/2020‐08/2024). Multivariable logistic regression models were adjusted for age, sex, NIH Stroke Scale (NIHSS), posterior circulation Alberta Stroke Program Early CT Score (pc‐ASPECTS), last‐known‐well‐to‐door time, and stroke etiology. Outcomes included 90‐day modified Rankin Scale (mRS), reperfusion rates, and intracranial hemorrhage (ICH) per Heidelberg classification. Results: Of 163 BAO patients, 75 (46.0%) received TNK and 88 (54.0%) received TPA. Rates of 90‐day good functional outcome (mRS 0–3) were comparable between groups (TNK: 61.8% vs. TPA: 48.8%, adjusted odds ratio [aOR] 1.372, 95% CI 0.616–3.054, p = 0.439). No significant differences were observed in rates of pre‐thrombectomy early reperfusion (18.7% vs. 14.8%, aOR 0.933, 95% CI 0.369–2.359, p = 0.884), post‐thrombectomy final reperfusion (97.3% vs. 92.0%, aOR 2.133, 95% CI 0.376–12.116, p = 0.393), 90‐day mortality (32.4% vs. 39.5%, aOR 0.989, 95% CI 0.436–2.244, p = 0.979), or symptomatic ICH (4.0% vs. 4.5%, aOR 1.319, 95% CI 0.245–7.114, p = 0.747). Predictors of favorable outcome included younger age, lower NIHSS, higher pc‐ASPECTS, shorter LKW‐to‐puncture time, and non‐atherothrombotic stroke etiology. Interpretation: In BAO stroke, TNK and TPA administered within 4.5 h pre‐EVT were associated with similar functional outcomes, reperfusion success and hemorrhage rates.

25 November 2025 in Annals of Neurology
Verified
Journal Article
Open access
DWDylan N. Wolman
Dylan N. Wolman
RKRahul R. Karamchandani
Rahul R. Karamchandani
SHSina Hemmer
Sina Hemmer
TBTyler M. Bielinski
Tyler M. Bielinski
NGNitin Goyal
Nitin Goyal
PHPhilipp Hendrix
Philipp Hendrix
Objective: The first‐pass effect (FPE), defined as excellent reperfusion after a single attempt, is associated with improved outcomes in large vessel occlusion stroke. We evaluated whether intravenous tenecteplase (TNK) compared with alteplase (TPA) increases the likelihood of FPE in basilar artery occlusion (BAO). Methods: We analyzed 163 consecutive BAO patients treated with intravenous TNK or TPA within 4.5 h of last known well across 14 U.S. stroke systems (January 2020–August 2024). Patients with early reperfusion ( n = 27) or aborted procedures ( n = 3) were excluded. Multivariable ordinal and logistic regression identified predictors of FPE (expanded Thrombolysis in Cerebral Infarction [eTICI] 2c–3) and modified FPE (mFPE, eTICI 2b–3), and FPE/mFPE association with 90‐day outcomes (modified Rankin Scale [mRS] 0–3). Results: FPE occurred in 55 of 133 patients (41.4%) and was more frequent with TNK than TPA (51.7% vs 32.9%, p = 0.029). TNK was independently associated with higher odds of FPE (adjusted odds ratio [aOR] 2.37, 95% confidence interval [CI] 1.13–4.98, p = 0.023) and mFPE (aOR 2.74, 95% CI 1.20–6.25, p = 0.017). Both FPE and mFPE were independently associated with ambulatory outcomes at 90‐days (FPE: aOR 2.94, 95% CI 1.18–7.33, p = 0.021; mFPE: aOR 5.11, 95% CI 1.81–14.43, p = 0.002). TNK compared with TPA did not show an independent association with functional outcome. Interpretation: In this multicenter BAO cohort, TNK increased the odds of achieving FPE compared with TPA. As FPE strongly predicted functional recovery, these findings suggest TNK may confer a reperfusion advantage with potential clinical benefit, although a direct outcome effect was not demonstrated. ANN NEUROL 2026;99:692–704

20 September 2016 in Pediatric Neurosurgery
Verified
Journal Article
Closed access
SRShivani D. Rangwala
Shivani D. Rangwala
DBDaniel M. Birk
Daniel M. Birk
MTMatthew K. Tobin
Matthew K. Tobin
YHYoon S. Hahn
Yoon S. Hahn
DNDemetrios C. Nikas
Demetrios C. Nikas
Nonaccidental head injury, as seen in domestic child abuse cases, is often associated with spinal injury, and spinal subdural hematoma is the most frequent diagnosis. While spinal epidural hematomas are a rare occurrence, the incidence of spontaneous epidural hematomas occurring in nonaccidental head injury patients is even lower. Epidural hematomas often result in acute focal neurological deficits necessitating emergent neurosurgical intervention. In patients without focal neurological deficits, conservative management may allow for spontaneous resolution of the epidural hematoma. The authors present the case of a 2-year-old boy with a large spinal epidural hematoma resulting after an event of nonaccidental injury, specifically, domestic child abuse. This patient exhibited no focal neurological deficits and was managed conservatively without surgical clot evacuation. On a follow-up visit, repeat imaging studies demonstrated a stable resolution of spinal epidural hematoma, providing further support for the safety of conservative management in these patients.

14 July 2017 in Pediatric Neurosurgery
Verified
Journal Article
Closed access
SRShivani D. Rangwala
Shivani D. Rangwala
MTMatthew K. Tobin
Matthew K. Tobin
DBDaniel M. Birk
Daniel M. Birk
JBJonathan T. Butts
Jonathan T. Butts
DNDimitrios C. Nikas
Dimitrios C. Nikas
YHYoon S. Hahn
Yoon S. Hahn
The anterior cingulate gyrus (ACG) is a continued focus of research as its exact role in brain function and vast connections with other anatomical locations is not fully understood. A review of the literature illustrates the role the ACG likely plays in cognitive and emotional processing, as well as a modulating role in motor function and goal-oriented behaviors. While lesions of the cingulate gyrus are rare, each new case broadens our understanding of its role in cognitive neuroscience and higher order processing. The authors present the case of an 8-year-old boy with a 1-month history of staring spells, agitated personality, and hyperphagia notable for the consumption of paper, who was found to have a 3-cm tumor in the left ACG. Following surgical resection of the tumor, his aggressive behavior and pica were ameliorated and the patient made an uneventful recovery, with no evidence of recurrence over the last 6 years since surgical resection. Here we discuss a unique behavioral presentation of pica, along with a review of the current literature, to illustrate functions of the ACG relevant to the location of the lesion.